| # |
AID |
Title |
Application |
Method |
Tested |
Active |
Status |
| 1 |
362 |
Formylpeptide Receptor Ligand Binding Assay |
NA |
Screening |
4282 |
61 |
Completed |
| 2 |
440 |
Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands
and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1)
Ligands |
1R03MH076381-01 |
Screening |
24304 |
181 |
Completed |
| 3 |
441 |
Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1)
Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor
(FPR) Ligands |
1R03MH076381-01 |
Screening |
24304 |
72 |
Completed |
| 4 |
519 |
Dose Response Assay for Formylpeptide Receptor (FPR)
Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1
(FPRL1) Ligands |
1R03MH076381-01 |
Confirmatory |
272 |
24 |
Completed |
| 5 |
520 |
Dose Response Assay for Formylpeptide Receptor-Like-1
(FPRL1) Ligands and Dose Response Counter-Screen Assay for
Formylpeptide Receptor (FPR) Ligands |
1R03MH076381-01 |
Confirmatory |
272 |
6 |
Completed |
| 6 |
698 |
Secondary Calcium Response Assay for Formylpeptide Receptor-Like-1 (FPRL1) Antagonists |
1R03MH076381-01 |
Screening |
7 |
3 |
Completed |
| 7 |
699 |
Secondary Calcium Response Assay for Formylpeptide Receptor (FPR) Antagonists |
1R03MH076381-01 |
Screening |
34 |
16 |
Completed |
| 8 |
722 |
Formylpeptide Receptor (FPR) Ligand Structure Activity Relationship (SAR) Analysis : Primary HTS Assay |
1R03MH076381-01 |
Screening |
1276 |
38 |
Completed |
| 9 |
723 |
Formylpeptide Receptor (FPR) Ligand Structure Activity
Relationship (SAR) Analysis : Dose Response Assay Counterscreen Against
Formyl Peptide Receptor-Like-1 (FPRL1) |
1R03MH076381-01 |
Confirmatory |
58 |
0 |
Completed |
| 10 |
724 |
Formylpeptide Receptor (FPR) Ligand Structure Activity Relationship (SAR) Analysis : Dose Response Assay |
1R03MH076381-01 |
Confirmatory |
58 |
15 |
Completed |
| 11 |
725 |
Formylpeptide Receptor (FPR) Ligand Structure Activity
Relationship (SAR) Analysis : Primary HTS Assay Counterscreen Against
Formyl Peptide Receptor-Like-1 (FPRL1) |
1R03MH076381-01 |
Screening |
1276 |
1 |
Completed |
| 12 |
762 |
Formylpeptide Receptor (FPRL1) Ligand Structure Activity Relationship (SAR) Analysis : FPR Dose Response Counterscreen Assay |
1R03MH076381-01 |
Confirmatory |
15 |
0 |
Completed |
| 13 |
763 |
Formylpeptide Receptor-Like-1 (FPRL1) Ligand Structure
Activity Relationship (SAR) Analysis : FPR Primary HTS Assay
Counterscreen |
1R03MH076381-01 |
Screening |
170 |
1 |
Completed |
| 14 |
765 |
Formylpeptide Receptor-Like-1 (FPRL1) Ligand Structure Activity Relationship (SAR) Analysis : Primary HTS Assay |
1R03MH076381-01 |
Screening |
170 |
3 |
Completed |
| 15 |
766 |
Formylpeptide Receptor (FPRL1) Ligand Structure Activity Relationship (SAR) Analysis : Dose Response Assay |
1R03MH076381-01 |
Confirmatory |
15 |
5 |
Completed |
| 16 |
805 |
Assay for Formylpeptide Receptor Family Ligands: Target Formylpeptide Receptor |
1R03MH076381-01 |
Summary |
15 |
15 |
Completed |
| 17 |
863 |
Formylpeptide Receptor (FPR) Structure Activity Relationship (SAR) Analysis: Secondary Calcium Response Assay for Antagonists |
1R03MH076381-01 |
Other |
15 |
9 |
Completed |
| 18 |
1061 |
Formylpeptide Receptor-Like-1(FPRL1) Structure Activity
Relationship (SAR) Analysis: Secondary Calcium Response Assay for
Antagonists |
1R03MH076381-01 |
Screening |
6 |
3 |
Completed |
| 19 |
1202 |
Assay for Formylpeptide Receptor Family Ligands: Target Formylpeptide Receptor-Like-1 |
1R03MH076381-01 |
Summary |
6 |
6 |
Completed |
| 20 |
757 |
HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype |
1RO3MH081231-01 |
Screening |
194655 |
521 |
Completed |
| 21 |
758 |
HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype |
1RO3MH081231-01 |
Screening |
194659 |
107 |
Completed |
| 22 |
759 |
HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype |
1RO3MH081231-01 |
Screening |
194653 |
267 |
Completed |
| 23 |
760 |
HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype |
1RO3MH081231-01 |
Screening |
194656 |
365 |
Completed |
| 24 |
761 |
HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype |
1RO3MH081231-01 |
Screening |
194656 |
398 |
Completed |
| 25 |
764 |
HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant |
1RO3MH081231-01 |
Screening |
194653 |
219 |
Completed |
| 26 |
751 |
Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent) |
1X01MH077613-01 |
Screening |
23718 |
39 |
Completed |
| 27 |
1062 |
Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent): Dose Response Assay |
1X01MH077613-01 |
Confirmatory |
21 |
2 |
Completed |
| 28 |
1207 |
Flow Cytometric GFP Protein Degradation Assay: Secondary Assay for disassembly of the 26S Proteasome |
1X01MH077613-01 |
Screening |
3 |
1 |
Completed |
| 29 |
1210 |
Estrogen Receptor (beta) binding: Primary Screen |
1X01MH077627-01 |
Screening |
822 |
58 |
Completed |
| 30 |
1211 |
Estrogen Receptor (alpha) binding: Primary Screen |
1X01MH077627-01 |
Screening |
822 |
71 |
Completed |
| 31 |
1212 |
GPR 30 Binding: Primary Screen |
1X01MH077627-01 |
Screening |
151 |
15 |
Completed |
| 32 |
1213 |
CALCIUM_SIGNALING_VIA_GPR30: Primary Screen |
1X01MH077627-01 |
Screening |
99 |
22 |
Completed |
| 33 |
1218 |
Functional assay for estrogen-mediated translocation of PIP3: Secondary Assay for Estrogen receptor beta |
1X01MH077627-01 |
Screening |
12 |
3 |
Completed |
| 34 |
1219 |
Functional assay to assess estrogen-mediated translocation of PIP3: Secondary Assay for GPR30 estrogen receptor |
1X01MH077627-01 |
Screening |
12 |
3 |
Completed |
| 35 |
1221 |
Estrogen Receptor (beta) binding: Dose Response of Primary Screen Assay |
1X01MH077627-01 |
Confirmatory |
63 |
14 |
Completed |
| 36 |
1223 |
Estrogen Receptor (alpha) binding: Dose Response of Primary Screen Assay |
1X01MH077627-01 |
Confirmatory |
63 |
17 |
Completed |
| 37 |
1224 |
GPR 30 Binding: Dose Response |
1X01MH077627-01 |
Confirmatory |
10 |
3 |
Completed |
| 38 |
1226 |
Functional assay for estrogen-mediated translocation of PIP3: Secondary Assay for Estrogen receptor alpha |
1X01MH077627-01 |
Screening |
12 |
4 |
Completed |
| 39 |
528 |
Allosteric Agonists for the VLA-4 Integrin |
1X01MH077638-01 |
Screening |
23786 |
2 |
Completed |
| 40 |
529 |
Allosteric Antagonists for the VLA-4 Integrin |
1X01MH077638-01 |
Screening |
23786 |
48 |
Completed |
| 41 |
576 |
Auto-fluorescence of compounds effecting screening of VLA-4 Integrin |
1X01MH077638-01 |
Other |
23785 |
146 |
Completed |
| 42 |
702 |
Dose-Response of Allosteric Antagonists for the VLA-4 Integrin |
1X01MH077638-01 |
Confirmatory |
62 |
34 |
Completed |
| 43 |
703 |
Dose-Response of Allosteric Agonists for the VLA-4 Integrin |
1X01MH077638-01 |
Confirmatory |
5 |
0 |
Completed |
| 44 |
795 |
MLSCN Assay for Activators of Prostate Cell Differentiation |
1X01MH078937-01 |
Screening |
23718 |
134 |
Completed |
| 45 |
1069 |
MLSCN Assay for Activators of Prostate Cell Differentiation: Single point confirmation of side scatter shift |
1X01MH078937-01 |
Screening |
430 |
50 |
Completed |
| 46 |
1076 |
MLSCN Assay for Activators of Prostate Cell Differentiation: Single point confirmation of potential cell killers |
1X01MH078937-01 |
Other |
430 |
29 |
Completed |
| 47 |
1196 |
MLSCN Assay for Activators of Prostate Cell Differentiation: Secondary Dose Response Assay |
1X01MH078937-01 |
Confirmatory |
95 |
35 |
Completed |
| 48 |
1197 |
MLSCN Assay for Activators of Prostate Cell Differentiation: Primary Screen Dose Response of Potential Cell Killers |
1X01MH078937-01 |
Confirmatory |
95 |
19 |
Completed |
| 49 |
1198 |
MLSCN Assay for Activators of Prostate Cell Differentiation: Primary Dose Response Assay |
1X01MH078937-01 |
Confirmatory |
95 |
29 |
Completed |
| 50 |
1200 |
MLSCN Assay for Activators of Prostate Cell Differentiation: Counter Screen Dose Response of Potential Cell Killers |
1X01MH078937-01 |
Confirmatory |
95 |
37 |
Completed |
| 51 |
527 |
Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing |
1X01MH078952-01 |
Screening |
24085 |
64 |
Completed |
| 52 |
700 |
Dose Response Assay for Inhibitors of Bacterial Quorum Sensing |
1X01MH078952-01 |
Confirmatory |
94 |
19 |
Completed |
| 53 |
1014 |
Inhibitors of Bacterial Quorum Sensing Structure Activity Relationship (SAR) Analysis: Primary HTS Assay |
1X01MH078952-01 |
Screening |
240 |
26 |
Completed |
| 54 |
1015 |
Inhibitors of Bacterial Quorum Sensing Structure Activity Relationship (SAR) Analysis: Dose Response Assay |
1X01MH078952-01 |
Confirmatory |
32 |
32 |
Completed |
| 55 |
1206 |
Inhibitors of Bacterial Quorum Sensing: Summary |
1X01MH078952-01 |
Summary |
45 |
45 |
Completed |
| 56 |
950 |
Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2 |
1X01MH079850-01 |
Screening |
134474 |
104 |
In progress |
| 57 |
951 |
Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B |
1X01MH079850-01 |
Screening |
134474 |
133 |
In progress |
| 58 |
952 |
Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W |
1X01MH079850-01 |
Screening |
134474 |
28 |
In progress |
| 59 |
1007 |
Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL |
1X01MH079850-01 |
Screening |
134474 |
69 |
In progress |
| 60 |
1008 |
Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1 |
1X01MH079850-01 |
Screening |
134474 |
179 |
In progress |
| 61 |
1009 |
Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 |
1X01MH079850-01 |
Screening |
134474 |
154 |
In progress |